Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders

American Journal of Clinical Pathology

Volumn 113, Issue 6, 2000, Pages 805-813

  McCarron, K F ^a   Hammel, J P ^a   Hsi, E D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

CD79b; Chronic lymphocytic leukemia; Chronic lymphoproliferative disorder; Flow cytometry; Leukemia

Indexed keywords

ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD79; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; LOGISTIC MODELS; LYMPHOMA, MANTLE-CELL; RECEPTORS, ANTIGEN, B-CELL; REPRODUCIBILITY OF RESULTS;

EID: 0034503024     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/G689-2J36-KCTC-WD5N     Document Type: Article

References (37)

1. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
2. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia, III: Evaluation of cell size by morphology and volume measurements
3. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia, II: Patterns of evolution of "prolymphocytoid" transformation
4. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia, I: Clinical and laboratory features of 300 patients and characterization of an intermediate group
5. Chronic lymphocytic leukaemia: Prognostic value of lymphocyte morphological subtypes: A multivariate survival analysis in 146 patients
6. The concept of typical and atypical chronic lymphocytic leukaemia
7. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia
8. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow: A clinicopathologic study of 40 patients
9. Discordant CD23 expression in mantle cell lymphoma
10. Expression of CD44 (HCAM) in small lymphocytic and mantle cell lymphoma
11. Translocation (11;14)(q13;q32) and overexpression of cyclin D1 protein in a CD23-positive low-grade B-cell neoplasm
12. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma
13. National Cancer Institute - Sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
14. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia
15. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia
16. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia
17. The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia
18. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)
19. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
20. The immunophenotype of hairy cell leukemia (HCL): Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes
21. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias
22. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders
23. Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy
24. Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells
25. Functional reconstitution of an immunoglobulin antigen receptor in T cells
26. Evidence for a direct physical interaction of membrane IgM, IgD, and IgG with the B29 gene product
27. Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta
28. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b)
29. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia
30. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia
31. CD79b immunophenotypic analysis in B-cell chronic lymphoproliferative disorders (B-CLPD) involving blood and bone marrow
32. CD5 negative diffuse mantle cell lymphoma with splenomegaly and bone marrow involvement
33. Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia
34. CD79 expression in B-cell chronic lymphocytic leukemia: Its implication for minimal residual disease detection
35. Quantitative analysis of CD79b, CD5, and CD19 in mature B-cell lymphoproliferative disorders
36. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia